2 days STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot Zacks
Stereotaxis’ latest regulatory approval in China is likely to offer a minimally-invasive treatment solution for complex arrhythmia patients and improve global cardiovascular care.
X